Good advice Stotes. I will. If you are correct, it means there is sufficient slack in the critical path for the FDA timetable to accommodate the additional Stage 3 work. If so, it means that the process to get to agreement on the endpoints for the validation trial is quite long. As you suggest, I will check with Scott. Cheers.
- Forums
- ASX - By Stock
- EMvision Research Notes
Good advice Stotes. I will. If you are correct, it means there...
-
- There are more pages in this discussion • 483 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
|
|||||
Last
$2.02 |
Change
-0.085(4.04%) |
Mkt cap ! $172.7M |
Open | High | Low | Value | Volume |
$2.12 | $2.16 | $2.02 | $109.7K | 52.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3111 | $2.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.06 | 9873 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3111 | 2.020 |
1 | 1000 | 2.000 |
2 | 29008 | 1.990 |
1 | 3000 | 1.980 |
1 | 1000 | 1.900 |
Price($) | Vol. | No. |
---|---|---|
2.060 | 9873 | 1 |
2.170 | 4000 | 1 |
2.200 | 17000 | 2 |
2.220 | 1350 | 1 |
2.240 | 651 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |